Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy
Hongli Jiang(China Pharmaceutical University), Wei Qu(China Pharmaceutical University), Tongzhong Tang(China Pharmaceutical University), Haopeng Sun(China Pharmaceutical University), Ning Zhang(Shanghai University), Feng Feng(Nanjing Medical University)
Cited by 86
Related Papers
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
|Cell Metabolism|2018|332
Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
|European Journal of Medicinal Chemistry|2018|200